Business News12.02.19
Bringing the power of AI to routine imaging, Advanced intelligent Clear-IQ Engine (AiCE), Canon Medical’s Deep Learning Reconstruction (DLR) technology, is now being integrated across a broader portfolio of scanners with a wider range of clinical applications across modalities. Advanced intelligent Clear-IQ Engine (AiCE) was trained using vast amounts of high-quality image data, and features a deep learning neural network that can reduce noise and boost signal to quickly deliver sharp, clear and distinct images, further opening doors for advancements in CT and MR.
Marketed in the US by Canon Medical Systems USA Inc., this technology is currently cleared on the Aquilion ONE/GENESIS Edition and Aquilion Precision CT systems, and is pending U.S. Food and Drug Administration 510(k) clearance on the Aquilion ONE/PRISM Edition and Aquilion Prime SP CT systems, as well as the Vantage Galan 3T and Vantage Orian 1.5T MR systems.* Capabilities include:
“Prior to our Advanced intelligent Clear-IQ Engine (AiCE) technology, a reconstruction algorithm that produced preserved low contrast detectability, preserved spatial resolution, and markedly reduced noise and artifact—without requiring an increase in radiation dose or deterring workflow—was a tool that seemed intangible,” said Satrajit Misra, vice president, Marketing, Canon Medical Systems USA Inc. “With the expansion of this unique DLR method across modalities, we’re elevating diagnostic imaging capabilities for our customers by providing new opportunities for advancement and clinical applications.”
Learn more about Canon Medical’s premium CT and MR technology at this year’s RSNA annual meeting in Chicago, Dec. 1 – 6, 2019 (Booth #1933, South Level).
Canon Medical Systems USA Inc., headquartered in Tustin, Calif., markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and interventional X-ray equipment.
Canon Medical offers a full range of diagnostic medical imaging solutions including CT, X-ray, ultrasound, vascular and MR, as well as a full suite of Healthcare IT solutions, across the globe. Its mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide. The company's goal is to deliver optimum health opportunities for patients through performance, comfort, and safety features.
*Advanced intelligent Clear-IQ Engine (AiCE) MR pending 510(k) clearance on the Vantage Galan 3T and Vantage Orian 1.5T systems. AiCE MR is applicable to neuro and knee imaging.
Aquilion, Celesteion, Vantage Galan, Vantage Orian and Made for life are trademarks of Canon Medical Systems.
Marketed in the US by Canon Medical Systems USA Inc., this technology is currently cleared on the Aquilion ONE/GENESIS Edition and Aquilion Precision CT systems, and is pending U.S. Food and Drug Administration 510(k) clearance on the Aquilion ONE/PRISM Edition and Aquilion Prime SP CT systems, as well as the Vantage Galan 3T and Vantage Orian 1.5T MR systems.* Capabilities include:
- High-quality images with the differentiation of true signal from noise through deep learning innovation to match the spatial resolution and low-noise properties of advanced scanning and reconstruction.
- Seamless integration into routine practice.
- Preferred image quality over non-AI reconstruction images following a clinical evaluation in MR, and where previously in CT, advanced approaches like MBIR had limited adoption due to perceived artificial texture. (Aquilion ONE/GENESIS Edition with Advanced intelligent Clear-IQ Engine (AiCE) image noise appearance is more similar to standard filtered back projection than FiRST).
“Prior to our Advanced intelligent Clear-IQ Engine (AiCE) technology, a reconstruction algorithm that produced preserved low contrast detectability, preserved spatial resolution, and markedly reduced noise and artifact—without requiring an increase in radiation dose or deterring workflow—was a tool that seemed intangible,” said Satrajit Misra, vice president, Marketing, Canon Medical Systems USA Inc. “With the expansion of this unique DLR method across modalities, we’re elevating diagnostic imaging capabilities for our customers by providing new opportunities for advancement and clinical applications.”
Learn more about Canon Medical’s premium CT and MR technology at this year’s RSNA annual meeting in Chicago, Dec. 1 – 6, 2019 (Booth #1933, South Level).
Canon Medical Systems USA Inc., headquartered in Tustin, Calif., markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and interventional X-ray equipment.
Canon Medical offers a full range of diagnostic medical imaging solutions including CT, X-ray, ultrasound, vascular and MR, as well as a full suite of Healthcare IT solutions, across the globe. Its mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide. The company's goal is to deliver optimum health opportunities for patients through performance, comfort, and safety features.
*Advanced intelligent Clear-IQ Engine (AiCE) MR pending 510(k) clearance on the Vantage Galan 3T and Vantage Orian 1.5T systems. AiCE MR is applicable to neuro and knee imaging.
Aquilion, Celesteion, Vantage Galan, Vantage Orian and Made for life are trademarks of Canon Medical Systems.